Rifampicin 150mg capsules

Country: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Rifampicin

থেকে পাওয়া:

Alliance Healthcare (Distribution) Ltd

এটিসি কোড:

J04AB02

INN (International Name):

Rifampicin

ডোজ:

150mg

ফার্মাসিউটিকাল ফর্ম:

Oral capsule

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 05010900

তথ্য লিফলেট

Colours
Non-Print
Colours
Date:
Time:
Equate CMYK
with
Dimensions
Main Font
Body Text Size
Min Text Size used
Page Count
No. of colours
Description
Component Type
Affiliate Item Code
Superceded Affiliate Item Code
TrackWise PR No.
MA No.
Packing Site/Printer
Supplier Code
Sign-offs
v3/July 2017
Pharma Code
SAP No.
Vendor Job No.
Trackwise Proof No.
Client Market
Keyline/Drawing No.
Barcode Info
3D Render ID
04 Dec 2019
I/I
17:01
Varnish
Free
Keyline
Rifampicin 150 mg 100
Label Leaflet
1941667
1618364
1941667
PL 04569/0086
NA
LL0540AC
261
NA
385177
8
United Kingdom
NA
5016695700021
NA
4
Myriad Pro
52 x 110 mm
8 pt
4 pt
Colours
Non-Print
Colours
Date:
Time:
Equate CMYK
with
Dimensions
Main Font
Body Text Size
Min Text Size used
Page Count
No. of colours
Description
Component Type
Affiliate Item Code
Superceded Affiliate Item Code
TrackWise PR No.
MA No.
Packing Site/Printer
Supplier Code
Sign-offs
v3/July 2017
Pharma Code
SAP No.
Vendor Job No.
Trackwise Proof No.
Client Market
Keyline/Drawing No.
Barcode Info
3D Render ID
04 Dec 2019
II/II
17:01
Varnish
Free
Keyline
Rifampicin 150 mg 100
Label Leaflet
1941667
1618364
1941667
PL 04569/0086
NA
LL0540AC
261
NA
385177
8
United Kingdom
NA
5016695700021
NA
4
Myriad Pro
52 x 110 mm
8 pt
4 pt
Braille
Rifamp-
icin
#150 mg
capsule
Rifamp-
icin
#150 mg
capsule
Colours
Non-Print
Colours
Date:
Time:
Equate CMYK
with
Dimensions
Main Font
Body Text Size
Min Text Size used
Page Count
No. of colours
Description
Component Type
Affiliate Item Code
Superceded Affiliate Item Code
TrackWise PR No.
MA No.
Packing Site/Printer
Supplier Code
Sign-offs
v3/July 2017
Pharma Code
SAP No.
Vendor Job No.
Trackwise Proof No.
Client Market
Keyline/Drawing No.
Barcode Info
3D Render ID
04 Dec 2019
1/48
17:01
Rifampicin 150 mg 100
Label Leaflet
1941667
1618364
1941667
PL 04569/0086
NA
LL0540AC
261
NA
385177
8
United Kingdom
NA
5016695700021
NA
4
Black
Myriad Pro
52 x 110 mm
8 pt
4 pt
PMS
7508
PMS
334
PMS
306
1
PEEL HERE BUT DO NOT REMOVE
150
MG
RIFAMPICIN
150 MG
CAPSULES
100 capsules
EACH CAPSULE C

পণ্য বৈশিষ্ট্য

1.
NAME OF THE MEDICINAL PRODUCT
Rifampicin 150 mg Capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 150 mg rifampicin.
Excipients with known effect:
Each capsule contains 42 mg of lactose monohydrate.
Each capsule contains a trace (0.015 % w/w of the capsule cap) of
azorubine.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule, hard
Size 3 hard gelatin capsules with mauve body and maroon cap, marked
“RN 150” and “G”. (The
capsule contents are brick red).
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
TUBERCULOSIS: Rifampicin, used in combination with other active
anti-tuberculosis drugs, is indicated
in the treatment of all forms of tuberculosis, including fresh,
advanced, chronic and drug-resistant
cases. Rifampicin is also effective against most atypical strains of
mycobacteria.
PROPHYLAXIS OF MENINGOCOCCAL MENINGITIS: Prophylaxis of meningococcal
meningitis in close
contact adult and paediatric patients.
LEPROSY: Rifampicin is indicated in the combination treatment of
multibacillary and paucibacillary
leprosy in patients of all age groups.
HAEMOPHILUS INFLUENZAE: Propylaxis of _Haemophilus influenzae_ _type
b_ disease in close contacts.
OTHER INFECTIONS: Rifampicin is indicated in the treatment of
brucellosis, legionnaires disease, and
serious staphylococcal infections. Rifampicin should be used in
combination with another appropriate
antibiotic to prevent emergence of resistant strains of the infecting
organism.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Posology _
Tuberculosis
Rifampicin should be given with other effective anti-tuberculosis
drugs to prevent the possible
emergence of rifampicin resistant strains of mycobacteria.
_Adults_: The recommended single daily dose in tuberculosis is
8-12mg/kg.
Usual daily dose:
Patients weighing less than 50kg – 450mg
Patients weighing 50kg or more – 600mg
_Paediatric patients: _
_Children above 3 months_: Oral doses of 15 (10-20) mg/kg body weight
daily are recommended,
although a total daily d